tiprankstipranks
Trending News
More News >
Pascal Biosciences Inc (TSE:NEVI)
:NEVI
Canadian Market

Pascal Biosciences Inc (NEVI) Financial Statements

Compare
5 Followers

Pascal Biosciences Inc Financial Overview

Pascal Biosciences Inc's market cap is currently C$1.59M. The company's EPS TTM is C$; its P/E ratio is -17.66; Pascal Biosciences Inc is scheduled to report earnings on March 20, 2026, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Nov 25Feb 25Feb 24Nov 22Feb 22
Income Statement
Total RevenueC$ 1.70MC$ 1.55MC$ 671.54KC$ 0.00C$ 0.00
Gross ProfitC$ 396.31KC$ 1.08MC$ 392.94KC$ -8.29KC$ -16.32K
Operating IncomeC$ -290.45KC$ -220.15KC$ -868.13KC$ -556.88KC$ -1.08M
EBITDAC$ -32.66KC$ -48.07KC$ -271.56KC$ -468.09KC$ -1.07M
Net IncomeC$ -275.07KC$ -362.48KC$ -399.77KC$ -480.28KC$ -1.09M
Balance Sheet
Cash & Short-Term InvestmentsC$ 102.17KC$ 129.54KC$ 418.52KC$ 8.37KC$ 0.00
Total AssetsC$ 1.72MC$ 2.04MC$ 2.50MC$ 18.82KC$ 155.19K
Total DebtC$ 244.21KC$ 528.30KC$ 683.27KC$ 224.62KC$ 7.76K
Net DebtC$ 142.04KC$ 398.76KC$ 264.75KC$ 216.25KC$ 7.76K
Total LiabilitiesC$ 746.36KC$ 813.50KC$ 1.12MC$ 962.93KC$ 646.48K
Stockholders' EquityC$ 968.95KC$ 1.23MC$ 1.38MC$ -944.11KC$ -491.30K
Cash Flow
Free Cash FlowC$ 62.10KC$ -132.06KC$ -390.49KC$ -147.68KC$ -614.93K
Operating Cash FlowC$ 62.10KC$ -120.50KC$ -385.35KC$ -147.68KC$ -614.93K
Investing Cash FlowC$ 0.00C$ -11.56KC$ -947.71KC$ 8.98KC$ 0.00
Financing Cash FlowC$ -90.20KC$ -167.65KC$ 1.76MC$ 154.84KC$ 624.08K
Currency in CAD

Pascal Biosciences Inc Earnings and Revenue History

Pascal Biosciences Inc Debt to Assets

Pascal Biosciences Inc Cash Flow

Pascal Biosciences Inc Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.